trending Market Intelligence /marketintelligence/en/news-insights/trending/aVfAw-6Pe9ucmYg2BiXp9g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Collegium Pharmaceutical appoints director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Collegium Pharmaceutical appoints director

Collegium Pharmaceutical Inc. appointed Gwen Melincoff as a class III director, effective Aug. 9, with an initial term expiring at the next annual meeting of shareholders in 2018.

Melincoff is currently managing director at Gemini Advisors LLC and an adviser to Phase 1 Ventures and Verge Genomics.